Overview
Taurus Charge is a prescription compound medication marketed as a “3-in-1 ED medication” combining sildenafil (110 mg), tadalafil (22 mg), and apomorphine (3 mg) in a sublingual dissolvable tablet. Sold by Taurus Medical, Inc. at a discounted price of approximately $102 (down from a stated $199), the product is positioned as a faster-acting, longer-lasting, and more powerful alternative to conventional erectile dysfunction treatments. TutelaMedical.com examined Taurus Charge's claims, ingredient profile, regulatory status, and marketing practices to evaluate what consumers should know before engaging with this telehealth-driven service.
Product Claims
Taurus Charge makes bold performance claims. The product allegedly works in 15 minutes or less, remains active for up to 36 hours, delivers bigger and harder erections, and offers “2x the power of Ro Sparks” based on total active ingredient milligrams. The company describes it as an “arousal-boosting 3-in-1 formula” that outperforms competitors. Comparing total milligrams across different active pharmaceutical ingredients as a measure of “power” is pharmacologically meaningless, akin to claiming that a cocktail containing three different alcohols is inherently stronger than a single spirit because the total fluid ounces are higher. Each active ingredient operates through distinct mechanisms, and their combined milligrams do not create a linear power multiplier.
Ingredients and Dosage
Taurus Charge combines three active pharmaceutical ingredients: sildenafil (110 mg), tadalafil (22 mg), and apomorphine (3 mg). The sildenafil dose of 110 mg exceeds the standard maximum recommended dose of 100 mg for conventional sildenafil (Viagra). The tadalafil dose of 22 mg is slightly above the standard 20 mg dose for on-demand use (Cialis). Apomorphine (3 mg) is a dopamine agonist that was approved in some countries for ED under the brand name Uprima but was withdrawn from several markets due to limited efficacy and side effects including nausea and syncope. The sublingual delivery format is designed for faster absorption, bypassing first-pass metabolism. The combination of two PDE5 inhibitors in a single tablet is notably unconventional, as standard medical practice typically involves prescribing one PDE5 inhibitor at a time, not stacking them.
The Science
Sildenafil and tadalafil are individually well-studied, FDA-approved medications for erectile dysfunction with decades of clinical data supporting their efficacy. However, the combination of both PDE5 inhibitors in a single formulation lacks the same depth of evidence. The sales page references “studies of sublingual sildenafil and apomorphine” but does not cite specific publications or clinical trials evaluating this exact three-drug combination at these specific doses. Combining two PDE5 inhibitors raises legitimate questions about additive side effects, including hypotension, headache, visual disturbances, and priapism. The apomorphine component adds a dopamine-agonist mechanism that introduces additional side-effect risks including nausea, dizziness, and fainting, issues that contributed to its market withdrawal in some regions.
Pricing and Value
Taurus Charge is listed at $199 with a discounted price of $101.94. The service includes the compound medication, an online medical consultation, 24/7 medical support, and free discreet shipping. The online process involves a 2-minute intake questionnaire, review by a licensed California clinician within 12 to 24 hours, and delivery within 3 to 5 days. While the bundled telehealth model offers convenience, consumers should understand that the “consultation” is a brief questionnaire review rather than a comprehensive medical evaluation. The pricing is competitive within the telehealth ED market but higher than obtaining generic sildenafil or tadalafil separately through a traditional pharmacy with insurance coverage.
Red Flags
Several aspects of Taurus Charge's offering deserve scrutiny. The company's own disclaimer states that “Taurus is not a laboratory or a medical provider,” raising questions about its role in the prescribing and compounding chain. The products are described as compounded medications that “have not been approved by the FDA,” which means they have not undergone the rigorous efficacy and safety review required for FDA-approved drugs. The combination of two PDE5 inhibitors in a single dose is not standard medical practice and introduces compounded side-effect risks. The “2x the power” marketing claim based on total milligrams is misleading pseudopharmacology. The absence of any mentioned money-back guarantee is notable in a market where competitors typically offer satisfaction guarantees. The super-physiological doses of both sildenafil and tadalafil exceed standard prescribing guidelines for their individually approved formulations.
Who May Benefit
Men diagnosed with erectile dysfunction who have found inadequate results with standard-dose single-agent PDE5 inhibitors might theoretically be candidates for alternative approaches, but this should be managed by a urologist or sexual health specialist who can properly evaluate cardiovascular risk, medication interactions, and underlying causes. The convenience of telehealth prescribing does not eliminate the need for proper medical evaluation, particularly for a combination formulation that departs from established prescribing norms.
Bottom Line
Taurus Charge combines three active pharmaceutical ingredients at doses that exceed or approach standard maximums in an unapproved compounded formulation. While the individual components have established efficacy for erectile dysfunction, the specific combination has not been evaluated through FDA approval processes, and the marketing relies on misleading potency comparisons. The company explicitly states it is neither a laboratory nor a medical provider, and the brief online questionnaire does not substitute for comprehensive medical evaluation. Men experiencing erectile dysfunction should consult a qualified healthcare provider who can assess their cardiovascular health, review potential drug interactions, and recommend appropriately dosed, FDA-approved treatments before turning to unapproved combination compounds sold through telehealth funnels.
These statements have not been evaluated by the Food and Drug Administration. Compounded medications are not FDA-approved. The content on this page is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before starting any medication or supplement regimen.
Disclosure: TutelaMedical.com is an independent consumer-health research publication. This review was produced by TutelaMedical.com editorial staff. We may earn a commission if you purchase through links on our site, but this does not influence our assessments. Our reviews are based on publicly available information and are intended to help consumers make informed decisions.